Aims/hypothesis Resistin was originally identified as an adipocyte-derived factor upregulated during obesity and as a contributor to obesity-associated insulin resistance. Clinically, resistin has also been implicated in cardiovascular disease in a number of different patient populations. Our aim was to simultaneously address these phenomena. Methods We generated mice with modest adipocyte-specific resistin overexpression. These mice were crossed with mice deficient in the LDL receptor (Ldlr
elevated serum triacylglycerol levels and a reduced ability to clear triacylglycerol upon a challenge. Additional phenotypic changes, such as increased body weight and reduced glucose clearance, independent of the Ldlr −/− background, confirmed increased adiposity associated with a more pronounced insulin resistance. A hallmark of elevated resistin was the disproportionate increase in circulating leptin levels. These mice thus recapitulated both the proposed negative cardiovascular correlation and the insulin resistance. A unifying mechanism for this complex phenotype was a resistin-mediated central leptin resistance, which we demonstrate directly both in vivo and in organotypic brain slices. In line with reduced sympathetic nervous system outflow, we found decreased brown adipose tissue (BAT) activity. The resulting elevated triacylglycerol levels provide a likely explanation for accelerated atherosclerosis.
Conclusions/interpretation
Resistin overexpression leads to a complex metabolic phenotype driven by resistin-mediated central leptin resistance and reduced BAT activity. Hypothalamic leptin resistance thus provides a unifying mechanism for both resistin-mediated insulin resistance and enhanced atherosclerosis. Electronic supplementary material The online version of this article (doi:10.1007/s00125-014-3210-3) contains peer-reviewed but unedited supplementary material, which is available to authorised users.
Introduction
Resistin is a hormone that belongs to a family of small, cysteine-rich secreted proteins collectively termed resistinlike molecules (RELMs) [1] . The source of resistin differs between rodents and humans: in mice resistin is expressed primarily by adipocytes while in humans monocytes and macrophages are the main sources. Despite this species and expression profile difference, resistin derives its name from a positive correlation with obese insulin-resistant conditions in both mice [2, 3] and humans [4] . Murine studies support a direct role for resistin in insulin resistance. Retn −/− mice display reduced fasting glucose levels [5] , transgenic human resistin expressed in murine adipose tissue induces insulin resistance [6] and recombinant murine resistin reduces glucose uptake in cardiac myocytes [7] . Although the mechanisms by which resistin causes insulin resistance have not yet been wholly elucidated, work by Muse and colleagues suggests that central resistin action is driving hypothalamic-mediated peripheral metabolic responses in mice [8] .
The role of resistin in the pathogenesis of insulin resistance has been questioned due to conflicting data in human clinical studies, which have yielded no relationship between resistin and insulin sensitivity. However, several clinical studies have demonstrated a close correlation between resistin levels and the severity of cardiovascular disease, independent of established risk factors such as insulin resistance [9, 10] . Furthermore, experimental studies in vitro and in vivo suggest that resistin plays a direct role in the pathogenesis of atherosclerosis [10] [11] [12] [13] . Thus, it is possible that resistin exerts its pathophysiological effects more directly through its effects on atherosclerosis rather than on systemic insulin sensitivity.
Given the association of resistin with cardiovascular disease in humans, we hypothesised that chronically elevated resistin levels would also accelerate and/or aggravate atherosclerosis in mice. To test this hypothesis, we generated an Ap2 (also known as Fabp4)-promoter-driven Retn transgenic (tg) mouse model that demonstrates elevated circulating resistin levels and crossed it into the atherosclerosis-prone Ldlr −/− mouse background. This approach enables us to potentially disentangle the metabolic and atherogenic actions of chronically elevated resistin levels without the complications of pharmacological delivery. Hepatic steatosis measurement Quantification of hepatic steatosis (described in further detail in ESM Methods) was performed by either computerised tomography (CT) or through tissue extraction according to the Folch method.
Methods

Animals
Lipid clearance and oral glucose tolerance test An oral load of Intralipid at 15 μl/g or 1.4 mol/l glucose solution at 10 μl/g was given following, respectively, a 3 h and a 12 h fast (21:00-09:00 hours) fast. Serum samples were collected as indicated in the experiments. After 2 h, tissues were harvested and lipids were extracted using a chloroform-to-methanol-based extraction method. Samples were then counted for radioactivity.
Organotypic hypothalamic culture and measurement of phosphorylation of signal transducer and activator of transcription 3 Organotypic brain slices were obtained from 16 young male wild-type mice as previously described [14] and phosphorylation of signal transducer and activator of transcription 3 (STAT3) was determined by immunofluorescence. These methods are described in further detail in ESM Methods.
Primary brown adipocyte differentiation and culture The stromal vascular fraction of interscapular brown adipose tissue (BAT) was isolated and cultured for differentiation into mature brown adipocytes as described previously [15] and in ESM Methods.
Statistical methods Bar graph data are expressed as mean ± SD. Time-dependent data are expressed as mean ± SEM for visual clarity in curves. Unpaired parametric t tests were used for comparisons between groups and analysis of variance for time-dependent data. A p value of <0.05 was considered as significant and is indicated by a single asterisk (double asterisk indicates 0.05 < p < 0.01 and triple asterisk indicates p<0.001 compared with wild-type mice; asterisks are equivalently employed for concurrent changes by experimental condition).
Quantitative RT-PCR, aortic root analyses, leptin treatment, western blot and blood biochemistry methods These are described in the ESM Methods.
Results
Retn tg mice exhibit mild insulin resistance and increased atherosclerotic progression To test whether resistin plays a role in insulin resistance and the pathogenesis of atherosclerosis, we developed a mouse model that overexpresses murine resistin under the control of the Ap2-promoter (Fig. 1a) . Retn expression in Retn tg mice was predominantly confined to adipose tissues with only marginal levels of the Ap2-driven expression found in isolated peritoneal macrophages (Fig. 1a) . Male Retn tg mice fed a chow diet displayed an approximately ninefold elevation in circulating resistin levels when compared with wild-type mice; this increase was sevenfold in mice fed an atherogenic western diet (Fig. 1b) . While higher than on diet-induced obesity alone [2] , these transgene-driven levels are in a more physiological range than those observed in past models [16] . These mice allow us to address whether adipocyte-secreted resistin is a benign biomarker or plays an active role in the pathogenesis of cardiovascular disease.
Elevated resistin levels have been implicated in insulin resistance. An oral glucose tolerance test demonstrated no significant change in the insulin sensitivity of male Retn tg mice on chow diet (Fig. 1c) . Fed ad libitum western diet for 8 weeks, however, male Retn tg mice exhibited reduced glucose clearance by oral glucose tolerance (Fig. 1d) . To study the impact of chronically elevated resistin levels on atherosclerosis, we crossed Retn tg mice onto the atherosclerosisprone Ldlr −/− background. Our female mice on western diet displayed significantly increased fasting blood glucose ( Fig. 1e ) and a trend toward increased plasma insulin (Fig. 1f) . Male mice only exhibited higher basal glucose levels on western diet (ESM Fig. 1a ). Adiponectin levels were unaltered by the Retn transgene (Fig. 1g ). Retn tg mice therefore present only mild insulin resistance-ideal conditions in which to further examine the atherogenic and metabolic effects of increased levels of resistin. The combination of physiological resistin overexpression, mild insulin resistance and Ldlr −/− background, and western diet feed provide a platform to determine whether resistin does indeed drive atherosclerosis. After 8 weeks on the western diet, female Retn tg Ldlr −/− mice displayed an increase in atherosclerotic plaque area in the aortic root by Oil Red O and MAC2 staining compared with littermate control mice (Fig. 2a) . Plaque area quantification confirmed a small but significant increase in Oil-Red-O-positive ( Fig. 2b ) and MAC2-positive areas ( Fig. 2c ) in aortic cross-sections. Pathological examination confirmed no differences in plaque morphology, including necrotic core areas. Upon extended western diet feeding (15 weeks), the differences in atherosclerotic plaque size between genotypes were no longer present (ESM Fig. 2a ), indicating that resistin enhances arteriosclerotic progression but does not lead to a more severe terminal plaque size. Combined, these findings further support observations that resistin is mechanistically involved in both insulin resistance and atherosclerosis.
Resistin overexpression causes delayed triacylglycerol clearance To elucidate the underlying mechanism for the accelerated atherosclerosis in Retn tg Ldlr −/− female mice, we measured various known risk factors for cardiovascular disease in western-diet-fed animals. Fed circulating fatty acid (FA) levels were significantly elevated ( Fig. 3a ) but neither total cholesterol (Fig. 3b ) nor the cholesterol content across lipoprotein fractions ( Fig. 3c ) was altered. Circulating triacylglycerol levels were nearly double those in non-transgenic Ldlr −/− mice on western diet (Fig. 3d) ; there was also a striking difference between genotypes in VLDL-triacylglycerol content ( Retn tg mice present with increased adiposity and heightened leptin levels Beyond the increased triacylglycerol phenotype, Retn tg Ldlr −/− mice also exhibited an increased weight gain (Fig. 4a ). Though subtle, this effect was consistently noted in all cohorts. Measurements of cohorts containing 25 mice in each group achieved significance after 8 weeks on western diet (ESM Fig. 2d ). What was more apparent, however, was an increase in adiposity in the Retn tg Ldlr −/− mice. Inguinal (subcutaneous) and gonadal white adipose tissue (IWAT and GWAT) were significantly increased in mass and in relation to body weight (Fig. 4b) ; interscapular BAT, however, was not. Consistent with increased adipose tissue mass, plasma leptin levels were significantly elevated in Retn tg Ldlr −/− mice (Fig. 4c, ESM 1d ). An increase in leptin level is to be expected with an increase in body weight. This is apparent when leptin levels were plotted against individual body weights (Fig. 4e) . Upon doing that, it was clear that leptin levels in Retn tg Ldlr −/− mice were disproportionately higher given their body weight, consistent with a potentially impaired leptin action in target tissues. Liver weights were reduced in the female Retn tg Ldlr −/− mice (Fig. 4b ). Using our previously established CT-based method [17] , we found that hepatic steatosis was lower than expected in the Retn tg Ldlr −/− female mice (ESM Fig. 3a ).
After 15 weeks of western diet, the liver triacylglycerol and cholesterol content were significantly reduced in the Retn tg Ldlr −/− female mice compared with littermate controls (ESM Fig. 3b, c) . Hepatic VLDL secretion was comparable between genotypes (ESM Fig. 3d ). Sphingolipidomic analysis revealed no differences in the 28 sphingolipid species measured in the liver by mass spectroscopy (data not shown). Furthermore, quantitative RT-PCR analysis did not show any differences in expression levels of inflammatory cytokine genes, such as Tnf and Il1b, in the liver (data not shown). Liver function in Retn tg Ldlr −/− female mice was, therefore, normal and increased circulating triacylglycerol levels were not due to decreased liver uptake or prevailing inflammation in the liver-a potential peripheral target tissue for resistin [8] .
All weight and metabolic measurements were repeated in Retn tg male mice in a wild-type background fed both chow and western diets to eliminate potential confounding effects due to sex or LDL receptor deficiency. Trends and significant increases in body weight, adiposity and leptin levels and reduced liver lipids were still apparent under those conditions Fig. 1a-h ). Most notably, triacylglycerol clearance was significantly reduced in Retn tg male wild-type mice on chow diet (ESM Fig. 1i ), an effect lost once the mice were placed on western diet (ESM Fig. 1j ). Energy balance assessment using indirect calorimetry and food intake measurements did not show any measurable differences between chow-fed male genotypes (data not shown). This lack of difference is not surprising given the very mild weight gain phenotype in the Retn tg mice. Western diet exacerbated weight and metabolic differences in male mice (ESM Fig. 1b) , but also induced a metabolic dysregulation potentially greater than that caused by elevated resistin alone.
Reduced BAT activity in Retn tg Ldlr
−/− mice Reduced lipid clearance and increased leptin levels were the most prominent metabolic readouts measured with chronically elevated resistin levels. To explore these differences further, we first repeated the oral lipid clearance experiments with the addition of a tritium-labelled lipid tracer to identify the responsible tissue(s) with reduced lipid clearance. We detected a substantially reduced lipid uptake in BAT in the Retn tg Ldlr −/− mice compared with their littermate controls (Fig. 5a ). Lipid uptake in liver, muscle, heart and WAT was similar between genotypes. This supports a model in which the increased adipose tissue size in the Retn tg mice is due to a reduction in lipolysis rather than an increase in lipid uptake. At room temperature, BAT in Retn tg mice was visually less 'brown' and exhibited more unilocular cells than wild-type littermates upon histological examination ( Fig. 5b; ESM Fig. 4a ). Quantitative RT-PCR measurements of an array of BAT genes demonstrated a trend in reduced BAT-defining genes in Retn tg mice, with a significant reduction in Ucp1 (Fig. 5c ). Lower levels of uncoupling protein-1 (UCP-1) were confirmed in BAT isolated from Retn tg Ldlr −/− mice (ESM Fig. 4b ). To eliminate any potentially confounding systemic metabolic effects in intact mice, brown pre-adipocytes were isolated from wild-type and Retn tg mice and induced to differentiate into mature brown adipocytes in vitro. The cells isolated from the transgenic mice differentiated equally well (ESM Fig. 4c ) but exhibited a reduced 'brown' gene expression profile (ESM Fig. 4d ), suggesting a potential cell-autonomous component to this BAT phenotype as well. The adrenergic response to isoprenaline was still present, but muted by overall reduced gene levels of Ppargc1a and Ucp1 in newly differentiated brown adipocytes (ESM Fig. 4e ).
To assess further functional consequences of reduced BAT activity, mice were challenged by housing them at a cooler temperature (6°C). This led to a more pronounced initial drop in body temperature in the Retn tg Ldlr −/− mice compared with their littermate controls (Fig. 5d) . Thereafter, both genotypes were able to maintain normal body temperature despite the cool ambient temperature. However, the Retn tg Ldlr −/− mice lost consistently more body weight, at least during the first few days, indicating a higher energy cost for the maintenance of body temperature in these mice (Fig. 5e ). These data suggest that BAT-driven, non-shivering thermogenesis (NST) is reduced in the presence of elevated resistin levels. Reduced BAT function and lipid clearance provide an explanation for the heightened triacylglycerol levels in the Retn tg mice.
Resistin causes central leptin resistance An increase in circulating leptin is a potential reflection of central leptin resistance. We therefore hypothesised that chronically elevated resistin levels lead to leptin resistance and consequently a reduced sympathetic nervous system (SNS) outflow. This might explain both the susceptibility to weight gain and, at least in part, to BAT function, including reduced lipid clearance. Chow-and western-diet-fed male wild-type and Retn tg mice were treated intraperitoneally with recombinant leptin and weight loss was measured over a period of 5 days. Indeed, Retn tg mice on the chow diet had a reduced leptin response with respect to acute body weight loss (Fig. 6a) . Interestingly, this effect was not present in western-diet-fed mice, with an upregulation of the endogenous leptin and resistin secretion in both strains ( Fig. 1b; ESM Fig. 4d) . To bypass the complex systemic metabolic perturbations, we tested the effect of resistin directly on hypothalamic leptin signalling in two ways. First, leptin was delivered into the third cerebral ventricle via intracerebroventricular (ICV) injection. Retn tg mice exhibited a blunted response to ICV injection of leptin, as judged by STAT3 phosphorylation in the hypothalamic arcuate nucleus (Fig. 6b, c) , compared with wild-type littermates. These acute observations confirm the effects of chronic resistin overexpression on leptin resistance that also manifested in a trend towards reduced gene expression of both Ldlr and inhibitors of leptin signalling in the hypothalamus of Retn tg mice (ESM Fig. 5a ). Second, to assess this signalling free from the systemic metabolic differences, organotypic hypothalamic sections from wild-type mice were pre-treated with or without resistin and then activated by leptin. Acute resistin treatment inhibited leptin-mediated STAT3 phosphorylation (Fig. 6d ) in hypothalamic sections (Fig. 6e) ; variability in surviving tissue volumes likely increased pSTAT3 variation (ESM Fig. 5b ). It should be noted that resistin alone acutely increased pSTAT3 in our in vitro experiments, supporting previous findings [18] . These combined in vivo and in vitro measures of reduced hypothalamic leptin responsiveness in the presence of resistin thus support a novel unifying mechanism ( Fig. 7) of central resistin-mediated metabolic effects.
Discussion
Our overexpressing Retn tg mouse model demonstrates significant atherogenic and metabolic differences in Ldlr −/− mice as a function of circulating resistin levels. These effects are more striking in female mice than in male mice, in which similar trends were observed. While in male mice many of these differences fail to reach statistical significance, male mice are in general more prone to diet-induced weight gain Proposed model for resistin-mediated metabolic differences. Increased resistin levels cause central leptin resistance. This reduces sympathetic outflow from the brain and particularly affects BAT, which also experiences reduced BAT marker expression in a tissue-autonomous fashion in the transgenic state. Functionally impaired BAT is responsible for the delayed triacylglycerol clearance, impaired insulin sensitivity and, in the case of the Ldlr −/− background, more rapid atherosclerotic plaque formation and insulin resistance making them metabolically more challenged even at baseline. Male Retn tg mice, regardless of background, were inherently more leptin resistant over the entire disease progression. Hence, having physiologically elevated resistin levels neither specifically accelerates the metabolic nor the atherogenic disease course in western-diet-fed male mice. However, elevated resistin quite strikingly affects female mice in which there is more room for modulation. The role of resistin as a modulator of atherogenesis is therefore critically dependent on the experimental setting. Importantly however, in the context of a wild-type background in the absence of an Ldlr −/− challenge, the effects on leptin resistance were observed in both sexes. Our Retn tg mice therefore offer an ideal setting for the careful deconvolution of multiple events that take place in different tissues, giving rise to a complex phenotype that would be nearly impossible to dissect in normal wild-type mice. The predominant unifying event with Retn overexpression appears to be accelerated weight gain through resistin-mediated central leptin resistance. One component of our proposed mechanism for resistin's central action is a reduction in sympathetic nervous activity to BAT resulting in reduced acute thermogenic response and lipid uptake. When recently measured by Kosari and colleagues, acute ICV administration of recombinant resistin indeed reduced BAT sympathetic nerve activity [19] . While supportive of our findings, there is a marked difference between the chronically elevated resistin levels in our model and the acute stimulation with pharmacological resistin levels in other work. Acute effects may trigger somewhat contradictory results under some circumstances. For example, central resistin infusion counteracts the effects of leptin by first elevating the phospo-STAT3/STAT3 ratio, food intake and body weight in diabetic rats; central resistin infusion also increased peripheral insulin sensitivity in this study [18] . Our ex vivo hypothalamic cultures confirmed this as a potential mechanism. The levels of peripheral resistin overexpression in our tg mice are, however, physiologically more meaningful in the context of chronic disease [2] . The model presented here thus provides a better setting in which to critically assess the effects of increased circulating resistin and distinguishes these mice from acute infusion studies or high-level overexpression [16] .
Along with adaptation to low temperatures, the capacity for NST increases through recruitment of BAT. This process critically depends on an increased activation of the SNS and subsequent β-adrenergic receptor signalling in BAT [20] . Mice housed at thermoneutrality (i.e. around 30°C) have very little capacity for NST, while mice housed at room temperature display at least some degree of cold adaptation in this regard. Thus, since the overall adiposity (i.e. insulation) is similar or possibly even increased in the Retn tg mice, these data suggest that the observed lower capacity for NST reflects a lower BAT activity in the Retn tg mice, at least during the first days of cold adaptation. Acutely administered resistin has such an effect [21, 22] . BAT activity is not only important for heat generation, but has also been proven to be highly important for triacylglycerol clearance [23] . Indeed, when resistin was reduced by siRNA in adipocytes, β-oxidation was increased [9] . In our tg mice with peripheral Retn overexpression, β-oxidative activity is decreased. A reduced ability for SNS activation also leads to a reduced rate of lipolysis in both WAT and BAT. This may not only explain increased adipose depot size, but is also consistent with reduced hepatic steatosis in Retn tg mice as a consequence of reduced substrate availability for hepatic triacylglycerol synthesis. While reduced SNS outflow naturally reduces lipolysis of WAT and BAT, the emerging insulin resistance that develops over time in the tg mice will push the system increasingly towards enhanced lipolysis in the fed state. Nevertheless, the net effects in the Retn tg mice appear to be a reduced lipolytic activity and increased adiposity that persists.
The reduced expression of 'brown' genes, such as Ucp1, Cidea and Ppargc1a in cultured brown Retn tg adipocytes suggests that resistin exerts effects directly on brown adipocytes, independent of its central impact on hypothalamic leptin signalling. Previous results in Retn −/− mice demonstrated decreased UCP-1 levels, but only in the absence of leptin signalling on an ob/ob background [5] . These effects appear to be independent of the demonstrated effects of central resistin action on thermogenesis [21, 22] . While central effects and/or reduced SNS activity in the Retn tg BAT might cause epigenetic imprinting detectable even ex vivo, it seems most likely that the transgene-mediated overexpression of the characteristically white adipocyte-associated protein resistin in brown adipocytes may push these cells towards a 'whiter'-though still responsive-functional phenotype with increased endoplasmic reticulum stress or reduced mitochondrial activity [24, 25] . Although retention of cholesterol-rich lipoproteins within the sub-endothelial matrix of the arterial wall is a key initiator of atherosclerosis, we observe here increased atherosclerotic progression without elevated cholesterol levels in the Retn tg Ldlr −/− female mice. Instead, we find an association between elevated triacylglycerol levels and accelerated atherogenesis in the context of western diet and LDL receptor deficiency. The role of elevated triacylglycerol levels in the pathogenesis of atherosclerosis is not clear, but epidemiological data confirm an independent association of triacylglycerol levels with vascular risk [26] . An increased circulating leptin level may, on its own, drive increased atherosclerosis [27] , an effect that we cannot directly discount in our model and which may exacerbate disease progression. A significant body of data suggests that the FIZZ (found in inflammatory zone) family of molecules is strongly implicated in atherogenesis in mice and humans; many of these studies suggest a macrophage immunomodulatory role for the RELM proteins [28] . At this time we cannot exclude resistin from having a direct mechanism of action, driving the atherosclerotic phenotype of Retn tg Ldlr −/− mice through the immune system or an action on endothelium-a mechanism that may well be relevant in human disease and plays a role in some animal models [28, 29] . We have, however, identified a centrally mediated aggravated metabolic state in the Retn tg mice that offers an atherosclerotic driving force of weight gain, heightened leptin activity and elevated triacylglycerol levels. Regardless of whether resistin functions directly in the plaques themselves or through altering systemic lipid metabolism as we propose, these findings demonstrate the farreaching effects of adipokine function and highlight the role of adipokine signalling in the adipose-CNS axis of metabolic regulation.
